Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E6 oncoprotein from human papillomavirus type 16 (HPV16) is a viral protein that plays a central role in the development and maintenance of HPV-associated cancers, particularly cervical cancer. It induces cellular transformation and immortalization by promoting degradation of tumor suppressor p53 and interfering with its transcriptional activity. E6 also activates telomerase, inhibits apoptosis, and modulates immune responses, contributing to oncogenesis. Disruption of E6 function is a promising therapeutic strategy.
Inhibition of E6/E6AP interaction; Restoration of p53 function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 E6 Oncoprotein (E6).